Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01410 |
IL-3R alpha/CD123 Protein, Human, Recombinant (His)
CD123,interleukin 3 receptor, alpha (low affinity),interleuk... |
Human | HEK293 Cells |
IL-3R alpha/CD123 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 34.5 kDa and the accession number is P26951-1. | |||
TMPY-05418 |
IL-3R alpha/CD123 Protein, Human, Recombinant (hFc)
IL3RX,IL-3R α/CD123,h |
Human | HEK293 Cells |
IL-3R alpha/CD123 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 59.8 kDa and the accession number is P26951-1. | |||
TMPY-06793 |
IL-3R alpha/CD123 Protein, Human, Recombinant (His & Avi), Biotinylated
interleukin 3 receptor, alpha (low affinity),interleukin 3 r... |
Human | HEK293 Cells |
IL-3R alpha/CD123 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 36.34 kDa and the accession number is NP_002174.1. | |||
TMPY-06744 |
IL-3R alpha/CD123 Protein, Human, Recombinant (hFc & Avi), Biotinylated
IL3RX,IL3RAY,interleukin... |
Human | HEK293 Cells |
IL-3R alpha/CD123 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 61.62 kDa and the accession number is NP_002174.1. | |||
TMPK-00242 |
IL-3R alpha/CD123 Protein, Human, Recombinant (aa 19-305, His & Avi), Biotinylated
IL3RAY,IL-3R subunit alp... |
Human | HEK293 Cells |
Interleukin-3 receptor subunit alpha, also known as IL-3 receptor subunit alpha, IL-3R-alpha, CD123, and IL3RA, is a single-pass type I membrane protein which belongs to the type I cytokine receptor family and Type 5 subfamily.The specific alpha subunit of the interleukin-3 receptor (IL-3Ralpha, CD123) is strongly expressed in various leukemic blasts and leukemic stem cells and seems to be an excellent target for the therapy of leukemias. |